arBtrage CAPITALIZING MARKETS checking… Sign in

PMV Pharmaceuticals, Inc.

PMVP Health Care Biotechnology: Pharmaceutical Preparations
$1.12
▼ -5.9% Today
as of Jun 7, 07:24 ET
Last 30 days -21.13% Apr 28 → Jun 05
$1.09 $1.19 $1.29 $1.38 $1.48 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$1.18
High
$1.18
Low
$1.12
Volume
$314,639
Avg Vol
$624,268
Mkt Cap
$63M
P/E (TTM)
Beta
52w High
$1.88
52w Low
$0.91
Div Yield
Shares Out
$53M

Overview

52-week range
$0.91
$1.88
22% of range
Avg surprise (last 2)
+12.6%
Avg reaction (last 2)
+1.0%
50% positive
Latest IV / EM
1773%
EM ±245.5% · $3 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.41$-0.31$-0.21$-0.12$-0.02 Actual $-0.38Actual $-0.34Actual $-0.30Actual $-0.02Actual $-0.37Actual $-0.34Est $-0.37Actual $-0.41Actual $-0.40Actual $-0.34Est $-0.41 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-21M$-16M$-11M$-6M$-1M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 12, 2026Mar/2026 $-0.34 $-0.41 +17.1% 0.0% +2.2% earnings
Tue Sep 30, 2025Sep 2025 $-0.40 financials
Mon Jun 30, 2025Jun 2025 $-0.41 financials
Fri May 9, 2025Mar/2025 $-0.34 $-0.37 +8.1% -0.1% earnings
Mon Sep 30, 2024Sep 2024 $-0.37 financials
Sun Jun 30, 2024Jun 2024 $-0.02 financials
Sun Mar 31, 2024Mar 2024 $-0.30 financials
Sat Sep 30, 2023Sep 2023 $-0.34 financials
Fri Jun 30, 2023Jun 2023 $-0.38 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-19M$-23M$-23M$-22M$-22M$-20M
Net income$-18M$-21M$-21M$-17M$-19M$-1M
EPS (diluted)$-0.34$-0.40$-0.41$-0.34$-0.37$-0.02

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$39M$38M$36M$44M$51M$41M$49M$49M
Inventory
Total current assets$96M$115M$132M$145M$163M$176M$190M$219M
Total assets$97M$117M$134M$153M$171M$191M$223M$238M
Long-term debt
Total liabilities$9M$12M$13M$12M$11M$15M$26M$23M
Total equity$88M$105M$121M$141M$160M$176M$198M$214M

Implied volatility — last 90 days

1767%1770%1772%1775%1777% Jun 07 — IV 1773% · EM ±245.5%

Sector peers